Disease |
Disease |
Method |
Sample |
Expression pattern |
Dysfunction type |
Description |
PMID |
Source |
B cell chronic lymphocytic leukemia |
a combination of genomic and cDNA library screening, RT-PCR, Northern blotting |
N/A |
N/A |
N/A |
As no mutations have been detected for leu1 or any other transcript so far described, we cannot exclude the existence of control elements within the rmd that may regulate expression of genes lying in this region. |
12094250 |
|
chronic lymphocytic leukemia |
chromatin-immunoprecipitation (ChIP) that are associated with activated transcription; semi-quantitative and quantitative methods (aPRIMES, BioCOBRA, MCIp, MassARRAY, and bisulfite sequencing) |
CLL cells |
N/A |
N/A |
the tumor suppressor mechanism at 13q14.3 is a cluster of genes controlled by two lncRNA |
23593011 |
|
multiple myeloma |
FISH |
myeloma cases |
N/A |
locus |
A cdr of approximately 350 kb was identified at 13q14 with the proximal border approximately 120 kb centromeric from d13s319, encompassing an area rich in expressed sequence tagged sites and containing dleu1, dleu2, and rfp2 genes. |
12461754 |
|
breast cancer |
microarray, qRT-PCR |
MCF-7 (ER-positive) and MDA-MB-231 cells (ER- negative) |
up-regulated |
interaction |
MiR-19a might be co-expressed with lncRNA-DLEU1 to co-regulate the expression of ESR1, which influences the occurrence and development of breast cancer cells with different levels of ER expression. |
26416600 |
|
head and neck squamous-cell carcinoma |
microsatellite repeat polymorphisms and PCR |
N/A |
N/A |
locus |
Multiplexed pcr revealed homozygous deletion of leu1 in one oral cavity tumor. |
10684931 |
|
B-cell chronic lymphocytic leukemia |
N/A |
N/A |
N/A |
expression |
Sequence analysis of the rna variants suggests that bcms transcripts belong to the group of non-coding rnas. |
11406609 |
|
B-cell chronic lymphocytic leukemia |
N/A |
N/A |
N/A |
expression |
Since their putative involvement in b-cll was controversial, our present study provide support for reconsidering the dleu1 and dleu2 genes as b-cll candidate genes |
11691637 |
|
inherited bone marrow failure disorder |
oligonucleotide microarray |
N/A |
up-regulated |
expression |
several oncogenes were found to be upregulated, including LARG, TAL1 and MLL, and of several tumour suppressor genes were downregulated, including DLEU1, RUNX1, FANCD2 and DKC1. Real time polymerase chain reaction confirmed statistically higher expression of LARG and TAL1 in SDS marrows. |
17539775 |
|
chronic lymphocytic leukemia |
qPCR etc. |
blood |
differential expression |
locus |
In 13q14.3, where several tumor suppressor genes, including the miRNA genes miR-16-1 and miR-15a, are co-regulated by the two long non-coding RNA genes DLEU1 and DLEU2 that span the critical region. |
19347735 |
LncRNADisease Lnc2Cancer
|
chronic lymphocytic leukemia |
qPCR, FISH etc. |
blood |
down-regulated |
mutation |
Frequently deleted in B-cell chronic lymphocytic leukemia. |
11161783 |
LncRNADisease Lnc2Cancer
|
chronic lymphocytic leukemia |
qPCR, FISH etc. |
blood |
differential expression |
N/A |
Leu1 and Leu2 genes are strong candidates as tumor suppressor gene(s) involved in B-CLL leukemogenesis. |
9395242 |
LncRNADisease Lnc2Cancer
|
|